Has John Scott, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,892 in general payments to John Scott, MD across 54 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Scott, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Scott, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Scott, MD

Pulmonary Disease · West Des Moines, IANPI 1972982619

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Eli Lilly at 48.8% of the total. Reporting peaked in 2019 at $1,512 and has fallen 86.8% since, to $200 in 2025.

$2,892in general payments, 2019–2025

Across 54 payments — averaging $53.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$1K
Jazz Pharmaceuticals Inc.$741
Inspire Medical Systems, Inc.$394
Harmony Biosciences LLC$124
Genentech USA, Inc.$100
Itamar Medical Inc$87
plus $35 from 1 others

$2,070,107in research payments, 2019–2025

Across 30 payments — averaging $69,004 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$2.1M

What the payments were for

Travel & lodging$1,18141%
Food & beverage$1,51652%
Education$1957%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	22	$1,412
Jazz Pharmaceuticals Inc.	10	$741
Inspire Medical Systems, Inc.	16	$394
Harmony Biosciences LLC	2	$124
Genentech USA, Inc.	1	$100
Itamar Medical Inc	2	$87
Avadel CNS Pharmaceuticals, LLC	1	$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XYREM$332
XYWAV$255

How this compares

$2,892 in reported general payments places this provider in the 60th percentile of 110 pulmonary disease providers in Iowa.

See all pulmonary disease providers in Iowa →

Medicare billing

Part B allowed, 2024

$188,012

Medicare patients

708

Services billed

2,174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OfevNintedanib Esylate	11	$137,298
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	140	$93,159
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	75	$36,627
Breo ElliptaFluticasone/Vilanterol	78	$29,861
Breztri AerosphereBudesonide/Glycopyr/Formoterol	16	$12,581
Incruse ElliptaUmeclidinium Bromide	26	$9,925
Arnuity ElliptaFluticasone Furoate	22	$7,238
Modafinil	22	$1,025
Bumetanide	23	$700
Prednisone	122	$601
Azithromycin	15	$578
Albuterol Sulfate HfaAlbuterol Sulfate	23	$527
Eszopiclone	15	$512
Armodafinil	12	$390
Gabapentin	29	$236

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in West Des Moines

Dustin McCannWest Des Moines$67K
Matthew TrumpWest Des Moines$41K
James MallenWest Des Moines$16K
Samantha Danielson-JonesWest Des Moines$11K
Ryan BrimeyerWest Des Moines$9K
Amerlon EnriquezWest Des Moines$7K
Daniel DodgeWest Des Moines$6K
Ryan MertensWest Des Moines$6K
Katrina GuestWest Des Moines$1K
Gregory HicklinWest Des Moines$422

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →